A RANDOMIZED, MULTI-CENTER, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO DETERMINE THE EFFECTS OF AMG-145 TREATMENT ON ATHEROSCLEROTIC DISEASE BURDEN AS MEASURED BY INTRAVASCULAR ULTRASOUND IN PATIENTS UNDERGOING CORONARY CATHERIZATION
Principal Investigator(s)
Feldman,Marc David
Funded by
AMGEN INC.
Research Start Date
Status
Inactive